Simplify Logo

Full-Time

Executive Assistant

Hybrid

Updated on 10/30/2024

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing for heart disease

Biotechnology
Healthcare

Compensation Overview

$101k - $155kAnnually

+ Cash Bonus + Stock Options

Senior

Mountain View, CA, USA

Expected to be in office 1 day per week to support C-Level meetings.

Category
Executive Support
Administrative & Executive Assistance
Requirements
  • Bachelor's Degree or relevant work experience required.
  • Experience working for medical device, diagnostic product development, or MedTech companies.
  • Excellent communicator and strategic thinker.
  • Proven problem solver who can work independently under little supervision.
  • 5+ years partnering with C-Level Executives.
  • Thrive in the fast-paced start-up environment while maintaining composer in stressful situations.
  • Experience successfully leading and growing a team is preferred.
Responsibilities
  • Administrative support for the CTO & SVP includes scheduling meetings, teleconferences, domestic and foreign travel, processing expense reports, organizing and planning company events.
  • Prepare corporate briefing materials and presentations for use in both internal and external meetings including with the Board, investors and other strategics.
  • Act as liaison for the CTO & SVP while maintaining strict confidentiality with both external facing contacts and internal relationships with the executive team, management, and employees. You will be the eyes and ears of the CTO & SVP.
  • Partner with the CTO & SVP to priorities tasks and proactively support the company’s objectives and goals. Take initiative and maintain open communication.
  • Partner with the People leader to maintain company culture and a cohesive environment for all.
  • Triage incoming calls and email. You will prioritize response needs and draft correspondence.
  • Anticipate the needs of the CTO & SVP and other executive team members.
  • Suggest and implement tools for company communication and collaboration to improve overall business processes.
  • Additional projects as assigned.

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company's product offerings include the HeartFlow Analysis, which consists of various analyses like FFRCT, RoadMap, and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries including the US, UK, Japan, and Canada. Unlike competitors, HeartFlow focuses on non-invasive solutions that enhance treatment planning and patient safety. The goal of HeartFlow is to improve cardiovascular care by providing advanced diagnostic tools that facilitate better treatment decisions.

Company Stage

Series F

Total Funding

$1.2B

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

6%

1 year growth

16%

2 year growth

19%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $215 million Series F funding round led by Bain Capital Life Sciences positions HeartFlow for significant growth and expansion.
  • HeartFlow's AI-enabled products, such as the RoadMap Analysis, enhance diagnostic accuracy and efficiency, potentially improving patient outcomes and physician workflows.
  • With coverage by 100% of Medicare and over 98% of commercial payers, HeartFlow's technology is widely accessible, increasing its adoption and market penetration.

What critics are saying

  • The cardiovascular care market is highly competitive, requiring continuous innovation to maintain a leading position.
  • Regulatory hurdles and the need for ongoing FDA clearances could delay product launches and market entry.

What makes HeartFlow unique

  • HeartFlow's non-invasive cardiac test offers a safer and more efficient alternative to traditional invasive procedures, setting it apart in the cardiovascular care market.
  • The company's comprehensive product portfolio, including FFRCT, RoadMap, and Plaque Analysis, provides a unique combination of anatomical and physiological visualization of coronary arteries.
  • HeartFlow's technology has received FDA clearance and is commercially available in multiple countries, ensuring a broad market reach and regulatory credibility.

Help us improve and share your feedback! Did you find this helpful?